Intrinsic Proteolytic Activities from Cancer Cells Are Sufficient to Activate Alkoxyamine Prodrugs and Induce Cell Death
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Protease-activatable alkoxyamine prodrugs show promise for cancer treatment. These prodrugs release cancer-killing radicals upon activation by specific proteases, demonstrating targeted cancer cell destruction.
Area Of Science
- Medicinal Chemistry
- Organic Chemistry
- Cancer Biology
Background
- Protease-activatable prodrugs offer enhanced specificity and reduced resistance in cancer therapy.
- Alkoxyamine prodrugs are designed to release cytotoxic free radicals upon enzymatic cleavage.
Purpose Of The Study
- To develop and evaluate novel alkoxyamine prodrugs activated by specific proteases for cancer treatment.
- To investigate the structure-activity relationship of peptide moieties in controlling protease activation.
- To assess the efficacy of these prodrugs against cancer cell lines and tumor explants.
Main Methods
- Synthesis of alkoxyamine prodrugs with varying peptide sequences (succinyl-Ala-Ala-Pro-Val-, PyroGlu-Gly-Arg-, PyroGlu-Gly-Lys-).
- Enzymatic activation studies using elastase and urokinase.
- Cytotoxicity assays on HT-1080 cells and protease inhibitor controls.
- Evaluation of prodrug activity on cancer cells from tumor explants.
Main Results
- Peptide modification successfully switched the activating enzyme from elastase to urokinase.
- Alkoxyamine prodrugs demonstrated potent cytotoxic activity against HT-1080 cells, which secrete active proteases.
- Cytotoxicity was dependent on protease activity and could be inhibited by protease inhibitors.
- Prodrugs effectively destroyed cancer cell lines and cancer cells from tumor explants.
Conclusions
- Alkoxyamine prodrugs can be designed for specific protease activation, offering a targeted cancer therapy approach.
- These prodrugs are effective against cancer cells, even with limited intrinsic protease activity.
- The developed prodrugs represent a promising strategy for cancer treatment with potential for reduced side effects.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...